Abstract
A rat sponge implant model was used to examine the role of protein kinase C (PKC) in angiogenesis, Neovascular response was determined by measurements of relative sponge blood flow by a133Xe clearance technique and confirmed histologically. Morphometric analysis was used to quantitate the amount of fibrovascular growth in the sponges. Daily doses of recombinant human basic fibroblast growth factor (bFGF, 100 ng), tumor necrosis factor-alpha (TNF-α, 50 ng), or interleukin1-alpha (IL-1α, 50 ng) caused neovascular responses that were blocked by daily coadministration of the selective PKC inhibitor, calphostin C (4μg). To confirm that calphostin C was able to inhibit PKC in vivo, its effect on the angiogenic response elicited by the PKC activator, phorbol 12-myristate 13-acetate (PMA, 30μg) was examined. The blood flow and morphometric data clearly showed that the intense neovascularization induced by PMA was totally suppressed by coadministration of calphostin C (4μg). Thus, these results suggest that cytokine-induced angiogenesis may be mediated in part through the activation of PKC and that selective inhibition of this enzyme could have therapeutic benefit in angiogenic diseases.
Similar content being viewed by others
References
Folkman, J., andM. Klagsbrun. 1987. Angiogenic factors.Science 235:442–447.
Folkman, J., andY. Shing. 1992. Angiogenesis.J. Biol. Chem. 267:10931–10934.
Fan, T.-P. D., andS. Brem. 1992. Angiosuppression.In The Search for New Anti-Cancer Drugs. M. J. Waring and B. A. J. Ponder editors. Cancer Biology Series, Vol. 3, Kluwer Academic Publishers, Lancaster, U.K. 185–229.
Fan, T.-P. D. 1994. Angiosuppressive therapy for cancer.Trends Pharmacol. Sci. 15:33–36.
Montesano, R., andL. Orci. 1985. Tumor-promoting phorbol esters induce angiogenesis in vitro.Cell 42:469–477.
Doctrow, S. R., andJ. Folkman. 1987. Protein kinase C activators suppress stimulation of capillary endothelial cell growth by angiogenic endothelial mitogens.J. Cell Biol. 104:679–687.
Morris, P. B., T. Hida, P. J. Blackshear, G. K. Klintworth, andJ. L. Swain. 1988. Tumor-promoting phorbol esters induce angiogenesis in vivo.Am. J. Physiol. 254:C318-C322.
Presta, M., J. A. M. Maier, andG. Ragnotti. 1989. The mitogenic signaling pathway but not the plasminogen activator-inducing pathway of basic fibroblast growth factor is mediated through protein kinase C in fetal bovine aortic endothelial cells.J. Cell Biol. 109:1877–1884.
Guesdon, F., N. Freshney, R. J. Waller, L. Rawlinson, andJ. Saklatvala. 1993. Interleukin 1 and tumour necrosis factor stimulate two novel protein kinases that phosphorylate the heat shock protein hsp27 andβ-casein.J. Biol. Chem. 268:4236–4243.
Saklatvala, J., L. M. Rawlinson, C. J. Marshall, andM. Kracht. 1993. Interleukin-1 and tumour necrosis factor activate the mitogen activated protein (MAP) kinase kinase in cultured cells.FEBS Lett. 334:189–192.
Hu, D. E., Y. Hori, M. Presta, G. A. Gresham, andT.-P. D. Fan. 1994. Inhibition of angiogenesis by IL-1 receptor antagonist and selected cytokine antibodies.Inflammation 18(1):45–58.
Hu, D. E., andT.-P. D. Fan. 1993. [Leu8]des-Arg9-bradykinin inhibits the synergistic interaction between bradykinin and interleukin-1 in angiogenesis.Br. J. Pharmacol. 109:14–17.
Fan, T.-P. D., D. E. Hu, S. Guard, G. A. Gresham, andK. J. Watling. 1993. Stimulation of angiogenesis by substance P and interleukin-1 in the rat and its inhibition by NK1 or interleukin-1 receptor antagonists.Br. J. Pharmacol. 110:43–49.
Kobayashi, E., H. Nakano, M. Morimoto, andT. Tamaoki. 1989. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C.Biochem. Biophys. Res. Commun. 159:548–553.
Andrade, S. P., T.-P. D. Fan, andG. P. Lewis. 1987. Quantitative in-vivo studies on angiogenesis in a rat sponge model.Br. J. Exp. Patho. 68:755–766.
Mayhew, T. M., andA. K. Sharma. 1984. Sampling schemes for estimating nerve fibre size. II. Methods for nerve trunks of mixed fascicularity.J. Anat. 139:45–58.
Nishizuka, Y. 1984. The role of protein kinase C in cell surface signal transduction and tumour promotion.Nature 308:693–698.
Daviet, I., J. M. Herbert, andJ. P. Maffrand. 1990. Involvement of protein kinase C in the mitogenic and chemotaxis effects of basic fibroblast growth factor on bovine cerebral cortex capillary endothelial cells.FEBS Lett. 259:315–317.
Dinarello, C. A. 1991. Interleukin 1 and interleukin 1 antagonism.Blood 77:1627–1652.
Hu, D. E., Y. Hori, andT.-P. D. Fan. 1993. Interleukin-8 stimulates angiogenesis in rats.Inflammation 17:135–143.
Leibovich, S. J., P. J. Polverini, H. M. Shepard, D. M. Wiseman, V. Shively, andN. Niseir. 1987. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha.Nature 329:630–632.
Fajardo, L. F., H. H. Kwan, J. Kowalski, S. D. Prionas, andA. C. Allison. 1992. Dual role of tumor necrosis factor-α in angiogenesis.Am. J. Pathol. 140:539–544.
Guy, G. R., S. P. Chua, N. S. Wono, S. B. Ng, andY. H. Tan. 1991. Interleukin 1 and tumour necrosis factor activate common multiple protein kinases in human fibroblasts.J. Biol. Chem. 266:14343–14352.
Bird, T. A., andJ. Saklatvala. 1990. Interleukin-1 signal transduction. Increased GTP binding and hydrolysis in membranes of a murine thymoma line (EL4).J. Biol. Chem. 265:235–240.
Muegge, K., andS. K. Durum. 1990. Cytokines and transcription factors.Cytokine 2:1–8.
Pepper, M. S., D. Belin, R. Montesano, L. Orci, andJ. D. Vassalli. 1990. Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro.J. Cell Biol. 111:743–755.
Niedbala, M. J., andM. S. Picarella. 1993. Role of protein kinase C in tumour necrosis factor induction of endothelial cell urokinase type plasminogen activator.Blood 81:2608–2617.
Mischak, H., J. H. Pierce, J. Goodnight, M. Kazanietz, P. M. Blumberg, andJ. F. Mushinski. 1993. Phorbol ester-induced myeloid differentiation is mediated by protein kinaseC-α andδ and not by protein kinase C-βII,-ge, -ζ, and-η.J. Biol. Chem. 268:20110–20115.
Wilkinson, S. E., andT. J. Hallam. 1994. Protein kinase C: Is its pivotal role in cellular activation over-stated?Trends Pharmacol. Sci. 15:53–57.
Hu, D. E., and T.-P. D.Fan. 1995. Suppression of VEGF-induced angiogenesis by the protein tyrosine kinase inhibitor lavendustin A.Br. J. Pharmacol. (in press).
Fotsis, T., M. Pepper, H. Adlercreutz, G. Fleischmann, T. Hase, R. Montesano, andL. Schweigerer. 1993. Genistein, a dietary-derived inhibitor of in vitro angiogenesis.Proc. Natl. Acad. Sci. U.S.A. 90:2690–2694.
Oikawa, T., K. Hirotani, M. Shimamura, H. Ashino-Fuse, andT. Iwaguchi. 1989. Powerful antiangiogenic activity of herbimycin A (named angiostatic antibiotic).J. Antibiot. 42:1202–1204.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hu, D.E., Fan, T.P.D. Protein kinase C inhibitor calphostin C prevents cytokine-induced angiogenesis in the rat. Inflammation 19, 39–54 (1995). https://doi.org/10.1007/BF01534379
Issue Date:
DOI: https://doi.org/10.1007/BF01534379